Intratympanic gentamicin treatment for Ménière’s disease: a randomized, double-blind, placebo-controlled trial on dose efficacy - results of a prematurely ended study

BACKGROUND: Gentamicin is used as a therapeutic agent for Ménière’s disease because of its vestibulotoxicity causing chemo-ablation of the vestibular sensory epithelia. Its use has increased in recent years. However, there is still no consensus about the dose regimen of gentamicin in the treatment o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bremer, Hendrik G, van Rooy, Ingrid, Pullens, Bas, Colijn, Carla, Stegeman, Inge, van der Zaag-Loonen, Hester J, van Benthem, Peter Paul, Klis, Sjaak F L, Grolman, Wilko, Bruintjes, Tjasse D
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Methodology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4141100/
https://ncbi.nlm.nih.gov/pubmed/25135244
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-15-328
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados